Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate
Influenza viruses pose a significant public health threat, causing seasonal epidemics and occasional pandemics with substantial morbidity and mortality worldwide.
Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality.
Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood
It is necessary to increase knowledge about the safety and effectiveness of influenza vaccination during pregnancy to improve awareness among patients and healthcare professionals and increase to increase vaccination coverage.
Comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children over multiple influenza seasons (2019–2023)
Annual vaccination with LAIV4 or IIV4 remains the best way to protect children against influenza infection.
Weekly US Influenza Surveillance Report: Key Updates for Week 23, ending June 7, 2025
Seasonal influenza activity is low. Nationally, during Week 23, the percentage of respiratory specimens testing positive for influenza virus in clinical laboratories was 1.7%.
News
Policy & Recommendations
The European Commission invests in the development of innovative products against respiratory viruses
The technology provides a universal solution to respiratory viruses, regardless of an individual's immune history – for example, people who do not sufficiently respond to a vaccine, or don't get vaccinated
BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza
Influenza A viruses (IAVs) pose a significant public health threat, with host factors play-ing a crucial role in disease severity.
News
Policy & Recommendations
EU Working Group on Respiratory Care kick-off meeting
This group will lead the development of a Call to Action to advocate for better access to treatments, in particular COVID- 19.